The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors.

MLA

Martínez-Feito, Ana, et al. “The Effect of Methotrexate versus Other Disease-Modifying Anti-Rheumatic Drugs on Serum Drug Levels and Clinical Response in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors.” Clinical Rheumatology, vol. 38, no. 3, Mar. 2019, pp. 949–54. EBSCOhost, https://doi.org/10.1007/s10067-018-4355-0.

APA

Martínez-Feito, A., Plasencia-Rodríguez, C., Navarro-Compán, V., Hernández-Breijo, B., González, M. Á., Monjo, I., Nuño, L., Nozal, P., Pascual-Salcedo, D., & Balsa, A. (2019). The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors. Clinical Rheumatology, 38(3), 949–954. https://doi.org/10.1007/s10067-018-4355-0

Chicago

Martínez-Feito, Ana, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, Borja Hernández-Breijo, María Ángeles González, Irene Monjo, Laura Nuño, Pilar Nozal, Dora Pascual-Salcedo, and Alejandro Balsa. 2019. “The Effect of Methotrexate versus Other Disease-Modifying Anti-Rheumatic Drugs on Serum Drug Levels and Clinical Response in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors.” Clinical Rheumatology 38 (3): 949–54. doi:10.1007/s10067-018-4355-0.